Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN37166280Phase 3Completed
Phase 3, randomised trial in coronary arteriosclerosis comparing Perindopril arm with Placebo arm (2 arms). Primary endpoint: Composite endpoint of cardiovascular mortality, non-fatal myocardial infarction and cardiac arrest resuscitation. Started Oct 1997; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN37166280.